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Arrhythmogenic right ventricular dysplasia (ARVD) is an inherited disorder of cardiomyocyte-to-cardiomyocyte adhesion pro-
teins associated with ventricular arrhythmias and sudden cardiac death. It is a characterized by progressive fibrofatty replace-
ment of right ventricular myocardium. The presence of adipose tissue either with or without fibrous tissue, scattered among 
cardiomyocytes is the histological hallmark of the disease.  Being in the myocardium, adipocytes trigger damage to cardio-
myocytes, thus causing electrical instability of the right ventricular myocardium, but the molecular pathogenesis of such an 
electrical instability in ARVD is still unclear.  Since (i) adipose tissue replacement of cardiomyocytes is the most essential histo-
logical finding in ARVD, (ii) nerve growth factor (NGF) exerts an arrhythmogenic effect related to sudden cardiac death, and (iii) 
adipose tissue produces NGF and brain-derived neurotrophic factor (BDNF),  the aim of the present study is to analyze immu-
nohistochemically ARVD-related adipocytes with special attention to the expression of NGF and related neurotrophins, BDNF 
and neurotrophin-3 (NT-3) and their respective TrkA, TrkB and TrkC receptors. Eight cases with ARVD were autopsy proven. The 
present results demonstrate that the intramyocardial adipocytes and cardiomyocytes in ARVD express NGF/TrkA and NT-3/TrkC, 
suggesting that they may play a substantial part in life-threatening myocardial electrical instability. 
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Introduction
Arrhythmogenic right ventricular dysplasia (ARVD), also 
known as arrhythmogenic right ventricular cardiomyopathy, 
was first described 40 years ago (1), while analyzing the causes 
of fatal ventricular arrytmias. Initially, young people were 
supposed to suffer from the disease, but later on it was established 
in elderly (2). Arrhythmogenic right ventricular dysplasia a 
predominantly genetically determined form of cardiomyopathy 
that is characterized histologically by the replacement of 
degenerated cardiomyocytes with adipose and fibrous tissue, 
and leads to arrhythmias, which account for approximately 20% 
of sudden cardiac death in the young (≤35 years). The estimated 
prevalence of ARVC in the general population ranges from 1 
in 2,000 to 1 in 5,000; men are more frequently affected than 
women. There have been 12 genes identified which are linked 
to dysfunctional desmosomes in ARVD. Examples of such 
defective desmosomal proteins are plakoglobin, desmoplakin, 
plakophilin-2 and desmoglein-2 (3-9). Recent data reveal that 
ARVD can be considered as a disease of the intercalated disc, 
rather than only as a desmosomal disease (10). Whereas in 
the past, the disease was considered to involve only the right 
ventricle, more recent clinical studies have established that the 
left ventricle is also involved, thus the term arrhythmogenic 
cardiomyopathy has emerged (9, 10).  
Despite increasing knowledge of the genetic basis of ARVD, 
we are just beginning to understand the molecular biology of 
ARVD-associated arrhythmogenic events.
The presence of mature adipocytes either with or without 
fibrous tissue, scattered among cardiomyocytes is the hallmark of 
the disease. Since (i) adipose tissue replacement of degenerated 
cardiomyocytes is the most essential histological finding in 
ARVD, (ii) nerve growth factor (NGF) exerts an arrhythmogenic 
effect related to sudden cardiac death (11, 12), and (iii) adipose 
tissue produces NGF and brain-derived neurotrophic factor 
(BDNF) (13), the aim of the present study was to analyze 
immunohistochemically ARVD-related adipocytes and 
cardiomyocytes with special attention to the expression of the 
neutrophins NGF, BDNF and neurotrophin-3 (NT-3) and their 
respective TrkA, TrkB and TrkC receptors. 
Subjects and methods 
The study is based on the autopsy findings in eight cases (five men 
and three women, age range 26÷59 years), all of them consistent 
with ARVD. Maximum optimal times after death and proper 
duration of tissue fixation in 10% neutral buffered formalin were 
provided. Gross examination and histological observation of all 
important organs and tissues was carried out on routinely stained 
after hematoxylin and eosin 4 micrometer thick tissue sections. 
In addition, immunohistochemical study of the expression 
of  NGF, BDNF and NT3 and their respective TrkA, TrkB and 
TrkC receptors was  done. Following the standard procedure in 
regard to antigen retrieval, reagents dilution, incubation time, 
negative controls, etc, primary antibodies, compatible with 
FLEX visualization system were  loaded in LINK automatic IHC 
stainer. All specimens were scanned by Aperio Slide scanner and 
digital images analyzed on a computer.
Results
ARVD is a rare disorder, but for a short period of time, eight 
cases were proven by autopsy in a relatively small region in 
the Northeastern part of Bulgaria. All of them shared similar 
history – sudden death during minor physical effort without any 
evidence of prior cardiovascular disease or complaints
The gross findings in all autopsy cases were consistent of 
signs for rapid occurring death – severe congestion in all 
viscera, without postmortem blood coagulation, presence of 
pulmonary and cerebral edema; no other significant lesions 
were found. Gross changes in the heart in all cases were minimal 
– slightly dilated cardiac ventricles with spotty endocardial 
surface and somewhat pale and streaky myocardial cut 
surface. Major arterial blood vessels showed minor degree of 
atherosclerotic involvement. Light microscopy findings in the 
dilated right ventricle myocardium included increased amount 
of adipose tissue forming massive layers (Fig. 1A) and features 
of hypertrophy of preserved cardiomyocytes, such as “boxcar” 
nuclei (Fig. 1B). In all of the cases, no features of inflammation 
were evident in the heart.
The myocardium of the left ventricle in all cases appeared 
normal except the presence of “wavy” fibers (data not shown).
Immunohistochemical study revealed positive expression 
of NGF and TrkA both in intramyocardial adipocytes as small 
dots at the periphery beneath the cellular membrane and in the 
cytoplasm of cardiomyocytes also as small dots on both sides of 
the nucleus (Fig 2. A,B) 
Immunohistochemical results of the expression of NT-3 and 
TrkB are presented on Fig. 3 A,B.
As for the other neurotrophin, BDNF and its receptor TrkB, 
and also the panneurotrophic receptor p75NTR no positive 
expression was established (data not shown).
Discussion 
As adipose tissue replacement of cardiomyocytes is the most 
essential histological finding in all of the autopsy cases, we 
consider the gross and light microscopy evidence presented 
above to be consistent with ARVD. All the cases studied here 
reveal the typical involvement of the heart without any other 
significant pathological changes to explain sudden death. In 
spite of the considerable progress in the understanding of the 
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Figure 1. Microphotograph of right ventricle myocardium: A, layers of mature adipocytes intermingled with cardiomyocytes; 




Figure 2.  Microphotograph of right ventricle myocardium with mature adipocytes; A, positive expression of NGF, and B. of TrkA; 
original magnification x100.
A B
Figure 3. Microphotograph of right ventricle; A, positive expression of NT-3 both in cardiomyocytes and adipocytes; original 
magnification x200, and B, very weak positive expression of TrkC in cardiomyocytes and adipocytes; original magnification x100.
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clinical presentation, the molecular pathogenesis of cardiac 
electrical instability in ARVD is still unclear. 
Whereas NGF and BDNF exert cardioprotective and 
metabotrophic action (14-17), the expression of NGF/TrkA and 
NT-3/TrkC in both cardiomyocytes and adipocytes suggests 
another possible - non-desmosomal - pathogenetic mechanism 
for myocardial electrical instability in ARVD (also see 11, 12). 
In that vein, a possibility of TrkA receptor antagonists (18) as 
potential antiarrhythmic drugs for ARVD may be examined.  
Other targets in the pathogenesis of ARVD might be (i) NGF-
mediated connexin phosphorylation of gap (channel) junctions 
(19), and (ii) neurotrophin- and catecholamine-dependent 
communication between cardiomyocytes and nerves (20).
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